Progressive plasticity during colorectal cancer metastasis

Andrew R Moorman(Memorial Sloan Kettering Cancer Center), Francesco Cambuli(Memorial Sloan Kettering Cancer Center), EK Benitez(Memorial Sloan Kettering Cancer Center), Qiang Jiang(Memorial Sloan Kettering Cancer Center), Yanting Xie(Memorial Sloan Kettering Cancer Center), Abdelrahman Mahmoud(Memorial Sloan Kettering Cancer Center), Melissa Lumish(Memorial Sloan Kettering Cancer Center), Saskia Hartner(Memorial Sloan Kettering Cancer Center), Sandy Balkaran(Memorial Sloan Kettering Cancer Center), Jonathan Bermeo(Memorial Sloan Kettering Cancer Center), Simran Asawa(Memorial Sloan Kettering Cancer Center), Canan Fırat(Memorial Sloan Kettering Cancer Center), Ashish Saxena(Memorial Sloan Kettering Cancer Center), Anisha Luthra(Memorial Sloan Kettering Cancer Center), Valeria Sgambati(Memorial Sloan Kettering Cancer Center), Kathleen Luckett(Memorial Sloan Kettering Cancer Center), Fan Wu(Memorial Sloan Kettering Cancer Center), Yun Li(Memorial Sloan Kettering Cancer Center), Zhengjun Yi(Memorial Sloan Kettering Cancer Center), Ignas Masilionis(Memorial Sloan Kettering Cancer Center), K Soares(Memorial Sloan Kettering Cancer Center), Emmanouil P. Pappou(Memorial Sloan Kettering Cancer Center), Rona Yaeger(Memorial Sloan Kettering Cancer Center), T. Peter Kingham(Memorial Sloan Kettering Cancer Center), William R. Jarnagin(Memorial Sloan Kettering Cancer Center), Philip B. Paty(Memorial Sloan Kettering Cancer Center), MR Weiser(Memorial Sloan Kettering Cancer Center), Linas Mažutis(Memorial Sloan Kettering Cancer Center), M.I. D’Angelica(Memorial Sloan Kettering Cancer Center), Jinru Shia(Memorial Sloan Kettering Cancer Center), Julio García‐Aguilar(Memorial Sloan Kettering Cancer Center), Tal Nawy(Memorial Sloan Kettering Cancer Center), TJ Hollmann(Memorial Sloan Kettering Cancer Center), Ronan Chaligné(Memorial Sloan Kettering Cancer Center), Francisco Sánchez-Vega(Memorial Sloan Kettering Cancer Center), Roshan Sharma(Memorial Sloan Kettering Cancer Center), Dana Pe’er(Memorial Sloan Kettering Cancer Center), Karuna Ganesh(Memorial Sloan Kettering Cancer Center)
bioRxiv (Cold Spring Harbor Laboratory)
August 21, 2023
Cited by 32Open Access
Full Text

Abstract

Abstract Metastasis is the principal cause of cancer death, yet we lack an understanding of metastatic cell states, their relationship to primary tumor states, and the mechanisms by which they transition. In a cohort of biospecimen trios from same-patient normal colon, primary and metastatic colorectal cancer, we show that while primary tumors largely adopt LGR5 + intestinal stem-like states, metastases display progressive plasticity. Loss of intestinal cell states is accompanied by reprogramming into a highly conserved fetal progenitor state, followed by non-canonical differentiation into divergent squamous and neuroendocrine-like states, which is exacerbated by chemotherapy and associated with poor patient survival. Using matched patient-derived organoids, we demonstrate that metastatic cancer cells exhibit greater cell-autonomous multilineage differentiation potential in response to microenvironment cues than their intestinal lineage-restricted primary tumor counterparts. We identify PROX1 as a stabilizer of intestinal lineage in the fetal progenitor state, whose downregulation licenses non-canonical reprogramming.


Related Papers